News

Jefferies Reaffirms Merck (MRK) ‘Buy’ Rating on Gardasil Dosing Stability
Merck & Co., Inc. (NYSE:MRK) is another biopharmaceutical company on the list of the 10 undervalued blue chip stocks analysts ...
Zacks Investment Research on MSN8h
MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal
Merck MRK announced that the phase III HYPERION study evaluating its pulmonary arterial hypertension (“PAH”) drug, Winrevair ...
Dermatology Advisor10h
Keytruda Gains HNSCC Indication for Perioperative Treatment
Keytruda (pembrolizumab) is approved for head and neck squamous cell carcinoma as a perioperative treatment regimen.
Healio10h
VIDEO: Pembrolizumab aids in the treatment of high-risk locally advanced cervical cancer
In this video, Susana M. Campos, MD, MPH, discusses results from the final analysis of the phase 3 A18 study in advanced cervical cancer, presented at ASCO Annual Meeting.The ...
Healio11h
VIDEO: New concurrent treatment shows benefit in vulvar cancer
In this video, Susana M. Campos, MD, MPH, discusses results from a single-arm phase 2 study of the concurrent treatment of vulvar cancer with chemoradiation and pembrolizumab.Patients who underwent ...
Merck Poised to Deliver Strong Results and Steady Dividend Growth
Merck & Co., Inc. (NYSE:MRK) is one of the Best Dividend Leaders to Buy Now. Merck & Co., Inc. (NYSE:MRK) has struggled over ...